Evidence map›Paper›PMID 33784255›Full record

ArticleJCI insight2021

An inducible Cre mouse for studying roles of the RPE in retinal physiology and disease.

Elliot H Choi, Susie Suh, David E Einstein, Henri Leinonen, Zhiqian Dong, Sriganesh Ramachandra Rao, Steven J Fliesler, Seth Blackshaw, Minzhong Yu, Neal S Peachey and 2 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Selective deletion ofiScience · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Retinal pigment epithelium 65 kDa protein (RPE65): An update.Progress in retinal and eye research · 2022
    Review
  16. Review
  17. Retinal Development and Pathophysiology in Kcnj13 Knockout Mice.Frontiers in cell and developmental biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Elliot H ChoiDepartment of Ophthalmology, Gavin Herbert Eye Institute, University of California, Irvine, Irvine, California, USA.
Susie SuhDepartment of Ophthalmology, Gavin Herbert Eye Institute, University of California, Irvine, Irvine, California, USA.
David E EinsteinDepartment of Physiology and Biophysics, School of Medicine, University of California, Irvine, Irvine, California, USA.
Henri LeinonenDepartment of Ophthalmology, Gavin Herbert Eye Institute, University of California, Irvine, Irvine, California, USA.
Zhiqian DongDepartment of Ophthalmology, Gavin Herbert Eye Institute, University of California, Irvine, Irvine, California, USA.
Sriganesh Ramachandra RaoDepartments of Ophthalmology and Biochemistry, Jacobs School of Medicine and Biomedical Sciences and.
Steven J FlieslerDepartments of Ophthalmology and Biochemistry, Jacobs School of Medicine and Biomedical Sciences and.
Seth BlackshawDepartment of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Minzhong YuDepartment of Ophthalmic Research, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Neal S PeacheyDepartment of Ophthalmic Research, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Krzysztof PalczewskiDepartment of Ophthalmology, Gavin Herbert Eye Institute, University of California, Irvine, Irvine, California, USA.
Philip D KiserDepartment of Ophthalmology, Gavin Herbert Eye Institute, University of California, Irvine, Irvine, California, USA.
University of California, Irvine · USCleveland Clinic · USVA Western New York Healthcare System · USJohns Hopkins University · US

Funding

University of Buffalo Clinical and Translational Science Institute - Supplement SchulyerUL1TR001412 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MURPHY, TIMOTHY F · 2015 to 2024
$33.8M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
STRUCTURAL STUDIES OF ARRESTINSR01EY009339 · NEI · UNIVERSITY OF WASHINGTON · PI KISER, PHILIP DAVID, PALCZEWSKI, KRZYSZTOF · 1992 to 2025
$16.0M
Use of systems pharmacology to prevent rod and cone photoreceptor degenerationR24EY027283 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI PALCZEWSKI, KRZYSZTOF · 2017 to 2021
$7.9M
RESOURCE/SERVICE CORE C - MOLECULAR INFORMATICS MODULEP30EY025585 · NEI · CLEVELAND CLINIC LERNER COM-CWRU · PI BELA ANAND-APTE · 2016 to 2026
$7.7M
PREDOCTORAL TRAINING PROGRAM IN MOLECULAR THERAPEUTICST32GM008803 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI MIEYAL, JOHN J, NIEMAN, MARVIN THOMAS · 2001 to 2023
$4.2M
Development and characterization of mouse models of RP59 DHDDS deficiencyR01EY029341 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI FLIESLER, STEVEN J., PITTLER, STEVEN J · 2018 to 2021
$2.2M
CRISPR/Cas9-Mediated Correction of Abca4 Mutations in a Stargardt Mouse ModelF30EY029136 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI SUH, SUSIE · 2019 to 2021
$152k
BLR&D Research Career Scientist AwardIK6BX005233 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI NEAL S. PEACHEY · 2020 to 2026
–
Retinoid cycles and retinal disease treatmentI01BX004939 · VA · VETERANS HEALTH ADMINISTRATION · PI KISER, PHILIP DAVID · 2020 to 2025
–
BLRD VA I01 BX004939BLRD VA IK6 BX005233NCATS NIH HHS UL1 TR001412NEI NIH HHS F30 EY029136NEI NIH HHS P30 EY025585NEI NIH HHS R01 EY009339NEI NIH HHS R01 EY029341NEI NIH HHS R24 EY027283NIGMS NIH HHS T32 GM007250NIGMS NIH HHS T32 GM008803
6 · The paper itself

Abstract

The retinal pigment epithelium (RPE) provides vital metabolic support for retinal photoreceptor cells and is an important player in numerous retinal diseases. Gene manipulation in mice using the Cre-LoxP system is an invaluable tool for studying the genetic basis of these retinal diseases. However, existing RPE-targeted Cre mouse lines have critical limitations that restrict their reliability for studies of disease pathogenesis and treatment, including mosaic Cre expression, inducer-independent activity, off-target Cre expression, and intrinsic toxicity. Here, we report the generation and characterization of a knockin mouse line in which a P2A-CreERT2 coding sequence is fused with the native RPE-specific 65 kDa protein (Rpe65) gene for cotranslational expression of CreERT2. Cre+/- mice were able to recombine a stringent Cre reporter allele with more than 99% efficiency and absolute RPE specificity upon tamoxifen induction at both postnatal days (PD) 21 and 50. Tamoxifen-independent Cre activity was negligible at PD64. Moreover, tamoxifen-treated Cre+/- mice displayed no signs of structural or functional retinal pathology up to 4 months of age. Despite weak RPE65 expression from the knockin allele, visual cycle function was normal in Cre+/- mice. These data indicate that Rpe65CreERT2 mice are well suited for studies of gene function and pathophysiology in the RPE.

Indexed as

Disease Models, AnimalMiceModels, AnimalAnimalscis-trans-IsomerasesGene Knock-In TechniquesIntegrasesMice, TransgenicReceptors, EstrogenReproducibility of ResultsRetinal DiseasesRetinal Pigment EpitheliumRetinoid IsomerohydrolaseSelective Estrogen Receptor ModulatorsTamoxifencis-trans-IsomerasesCre recombinaseIntegrasesReceptors, EstrogenRetinoid IsomerohydrolaseSelective Estrogen Receptor ModulatorsTamoxifenGeneticsMouse modelsOphthalmologyRetinopathy

Identifiers

PMID33784255
PMCPMC8262343
OpenAlexW3141396653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.